Original Article
Leukemia (2006) 20, 671–679. doi:10.1038/sj.leu.2404141; published online 23 February 2006
hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia
L J Campbell1, C Fidler1, H Eagleton1, A Peniket1, R Kusec2, S Gal1, T J Littlewood1, J S Wainscoat1 and J Boultwood1
- 1Leukaemia Research Fund Molecular Haematology Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK
- 2Department of Clinical Sciences, Department of Haematology, University Hospital Merkur, Zagreb, Croatia
Correspondence: Dr J Boultwood, Leukaemia Research Fund Molecular Haematology Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK. E-mail: jacqueline.boultwood@ndcls.ox.ac.uk
Received 8 August 2005; Revised 25 November 2005; Accepted 22 December 2005; Published online 23 February 2006.
Abstract
Telomere shortening is associated with disease progression in chronic myeloid leukaemia (CML). To investigate the biology and regulation of telomerase in CML, we evaluated expression of the telomerase components, its regulators and several telomeric-associated proteins. Quantitative real-time-polymerase chain reaction (PCR) was used to compare gene expression in the CD34+/leukaemic blast cells of 22 CML patient samples to the CD34+ cell population of healthy individuals. hTERT, the catalytic component of telomerase, was downregulated in eight of 12 chronic phase (CP) patients (P=0.0387). Furthermore, hTERT was significantly downregulated in two of three patients in accelerated phase (AP) and seven of seven patients in blast crisis (BC), P=0.0017. Expression of hTR and telomeric-associated proteins TEP1, TRF1, TRF2, tankyrase and PinX1 was high in the majority of CP and AP patients. With the exceptions of TEP1 and hTR, expression of these factors was highest in CP and decreased during disease progression. Expression of c-Myc, a positive regulator of hTERT transcription, correlated with hTERT expression and decreased with disease progression, falling below control levels in BC. hTERT levels were increased in CP patients following successful treatment with imatinib, relative to untreated CP patients. We suggest that reduced hTERT expression directly causes the shortened telomeres observed in CML.
Keywords:
telomerase, CML, haematopoietic stem cell, real time PCR, gene expression
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Telomere-Dependent Chromosomal Instability
Journal of Investigative Dermatology Symposium Proceedings Original Article
